According to a new study, psoriasis patients treated with methotrexate are almost three times more likely to develop nonmelanoma skin cancer when compared to those not on methotrexate.
top of page
it's where dermatology lives
bottom of page
According to a new study, psoriasis patients treated with methotrexate are almost three times more likely to develop nonmelanoma skin cancer when compared to those not on methotrexate.
Comments